The table below shows 10x Genomics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$26.12M
$34.35M
-$15.72M
-$4.13M
-$20.80M
-$4.08M
Capital expenditure
$1.60M
$1.89M
$2.91M
$4.56M
$28.14M
$38.87M
Investing cash flow
-$1.31M
-$1.89M
$10.63M
$119.96M
-$257.56M
-$44.32M
Dividends paid
-
-
-
-
TXG operating cash flow (10-K history)
10x Genomics, Inc. reported operating cash flow of $136.05M for fiscal year 2025. That is up 1941.6% from $6.66M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from -$10.70M (FY 2017) to $136.05M. Figures come from the company's audited annual reports as filed with the SEC.
